Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 10/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 8/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 8/20 | 0.50 |
| ▸ | DPP4 | P27487 | 5/20 | 0.50 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 5/20 | 0.44 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.39 |
| ▸ | METAP1 | P53582 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24833949 | 0.91 | DPP8 (0.44) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL30064530 | 0.87 | DPP8 (0.47) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL13232004 | 0.86 | DPP7 (0.44) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL13232005 | 0.85 | DPP8 (0.45) | DPP7DPP9DPP8DPP4BIRC2 | |
| SCHEMBL29233299 | 0.81 | SLC1A1 (0.40) | DPP9DPP8DPP4BIRC2METAP2 | |
| SCHEMBL30064548 | 0.81 | METAP2 (0.51) | CTSKCTSSMETAP2METAP1CA2 | |
| SCHEMBL30410094 | 0.81 | SLC1A1 (0.40) | DPP9DPP8DPP4BIRC2METAP2 | |
| SCHEMBL29233297 | 0.81 | SLC1A1 (0.40) | DPP9DPP8DPP4BIRC2METAP2 | |
| SCHEMBL7266730 | 0.81 | SLC1A2 (0.46) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL5967210 | 0.81 | SLC1A2 (0.46) | DPP7DPP9DPP8DPP4SLC15A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002422-A1 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002422-A1 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | NAAA, NOTUM, ASNS | DPP7 3716/4885DPP9 2961/4885DPP8 2812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.